FDA Inspection 1257602 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on Nov 8, 2024 in Knoxville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 8, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Knoxville, TN (United States)